These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 30460216

  • 1. Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders.
    Sawada A, Inoue M.
    Front Pediatr; 2018; 6():334. PubMed ID: 30460216
    [Abstract] [Full Text] [Related]

  • 2. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants.
    Ishimura M, Eguchi K, Shiraishi A, Sonoda M, Azuma Y, Yamamoto H, Imadome KI, Ohga S.
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [Abstract] [Full Text] [Related]

  • 3. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
    Yamamoto M, Shindo M, Funayama T, Sumi C, Saito T, Toki Y, Hatayama M, Imadome KI, Mizukami Y, Okumura T.
    Medicine (Baltimore); 2022 Mar 25; 101(12):e29055. PubMed ID: 35357349
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K.
    Am J Hematol; 2008 Sep 25; 83(9):721-7. PubMed ID: 18626884
    [Abstract] [Full Text] [Related]

  • 5. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development.
    Arai A.
    Front Pediatr; 2019 Sep 25; 7():14. PubMed ID: 30805320
    [Abstract] [Full Text] [Related]

  • 6. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R, Lin Q, Zhu Y, Shen Y, Xu Q, Tang H, Cui N, Jiang L, Dai X, Chen W, Li X.
    Orphanet J Rare Dis; 2023 Sep 22; 18(1):297. PubMed ID: 37736751
    [Abstract] [Full Text] [Related]

  • 7. NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.
    Shibata S, Takiuchi Y, Kawasaki N, Okamoto Y, Inano S, Fukunaga A, Tabata S, Arai A, Imadome KI, Kitano T.
    Int J Hematol; 2022 Apr 22; 115(4):595-599. PubMed ID: 35001347
    [Abstract] [Full Text] [Related]

  • 8. How we treat chronic active Epstein-Barr virus infection.
    Sawada A, Inoue M, Kawa K.
    Int J Hematol; 2017 Apr 22; 105(4):406-418. PubMed ID: 28210942
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland.
    Ai J, Xie Z.
    Front Pediatr; 2018 Apr 22; 6():289. PubMed ID: 30356785
    [Abstract] [Full Text] [Related]

  • 10. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
    Kawamoto K, Miyoshi H, Seto M, Kimura H, Ohshima K.
    Rinsho Ketsueki; 2019 Apr 22; 60(8):944-952. PubMed ID: 31484894
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S, Ko YH.
    J Dermatol; 2014 Jan 22; 41(1):29-39. PubMed ID: 24438142
    [Abstract] [Full Text] [Related]

  • 12. EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood.
    Hong M, Ko YH, Yoo KH, Koo HH, Kim SJ, Kim WS, Park H.
    Korean J Pathol; 2013 Apr 22; 47(2):137-47. PubMed ID: 23667373
    [Abstract] [Full Text] [Related]

  • 13. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
    Ali S, AlThubaiti S, Renzi S, Krueger J, Chiang KY, Naqvi A, Schechter T, Punnett A, Ali M.
    Pediatr Transplant; 2019 Feb 22; 23(1):e13319. PubMed ID: 30417487
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 22; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK.
    Leuk Lymphoma; 2017 Jan 22; 58(1):53-63. PubMed ID: 27157296
    [Abstract] [Full Text] [Related]

  • 16. Chronic active Epstein-Barr virus infection progresses to aggressive NK cell leukemia with a poor prognosis.
    Hu X, Yang Y, Chen L, Wan Y, Sheng L, Bao Y, Zheng M.
    Am J Transl Res; 2021 Jan 22; 13(10):12006-12015. PubMed ID: 34786135
    [Abstract] [Full Text] [Related]

  • 17. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.
    Watanabe Y, Sasahara Y, Satoh M, Looi CY, Katayama S, Suzuki T, Suzuki N, Ouchi M, Horino S, Moriya K, Nanjyo Y, Onuma M, Kitazawa H, Irie M, Niizuma H, Uchiyama T, Rikiishi T, Kumaki S, Minegishi M, Wada T, Yachie A, Tsuchiya S, Kure S.
    Eur J Haematol; 2013 Sep 22; 91(3):242-248. PubMed ID: 23734904
    [Abstract] [Full Text] [Related]

  • 18. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
    Guan YQ, Shen KF, Yang L, Cai HD, Zhang ML, Wang JC, Long XL, Xiong J, Gu J, Zhang PL, Xiao M, Zhang W, Zhou JF.
    Curr Med Sci; 2021 Jun 22; 41(3):482-490. PubMed ID: 34170459
    [Abstract] [Full Text] [Related]

  • 19. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
    Zheng M, Bao Y, Wang J, Ma Y, Yang Y, Zhang P, Chen L, Zheng K, Zhou J.
    Hematol Oncol; 2022 Aug 22; 40(3):381-389. PubMed ID: 35405763
    [Abstract] [Full Text] [Related]

  • 20. Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells.
    Wang J, Su M, Wei N, Yan H, Zhang J, Gong Y, Wu L, Suolitiken D, Pi Y, Song D, Chen L, Liu H, Yang S, Wang X, Wang Z.
    Blood; 2024 Jan 04; 143(1):32-41. PubMed ID: 37824804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.